We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+8.6%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$121B
AUM Growth
+$13.4B
(+12%)
Cap. Flow
+$5.79B
Cap. Flow
% of AUM
4.79%
Top 10 Holdings %
Top 10 Hldgs %
30.32%
Holding
1,514
New
81
Increased
876
Reduced
419
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.9B |
| 2 |
Agnico Eagle Mines
AEM
|
+$515M |
| 3 |
TSMC
TSM
|
+$514M |
| 4 |
Newmont
NEM
|
+$510M |
| 5 |
Broadcom
AVGO
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$649M |
| 2 |
Micron Technology
MU
|
+$645M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$338M |
| 4 |
SAND
Sandstorm Gold
SAND
|
+$298M |
| 5 |
Teradyne
TER
|
+$294M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.09% |
| 2 | Materials | 28.34% |
| 3 | Industrials | 7.1% |
| 4 | Healthcare | 5.35% |
| 5 | Financials | 3.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVGW
1326
DELISTED
Calavo Growers
CVGW
| $94K | ﹤0.01% |
4,338
+690
| +19% | +$15.3K |
|
|
STKL
1327
DELISTED
SunOpta
STKL
| $93K | ﹤0.01% |
24,438
+1,942
| +9% | +$8.82K |
|
1328
Compass Diversified
CODI
$924M
| $90K | ﹤0.01% |
18,822
+630
| +3% | +$3.98K |
|
1329
Fomento Económico Mexicano
FMX
$39.7B
| $89K | ﹤0.01% |
883
+54
| +7% | +$5.25K |
|
1330
Grupo Aeroportuario del Pacifico
PAC
$12.4B
| $87K | ﹤0.01% |
331
-3
| -0.9% | -$697 |
|
1331
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
| $85K | ﹤0.01% |
885
+183
| +26% | +$17.7K |
|
1332
Braskem
BAK
$825M
| $84K | ﹤0.01% |
28,537
-19,823
| -41% | -$54.3K |
|
1333
Invesco QQQ Trust
QQQ
$487B
| $77K | ﹤0.01% |
126
| – | – |
|
1334
Dr. Reddy's Laboratories
RDY
$10.3B
| $76K | ﹤0.01% |
5,448
-3,907
| -42% | -$54.8K |
|
1335
Tandem Diabetes Care
TNDM
$1.61B
| $75K | ﹤0.01% |
3,430
+1,381
| +67% | +$24.9K |
|
1336
Corporacion America
CAAP
$6.42B
| $73K | ﹤0.01% |
2,808
+1,528
| +119% | +$34.2K |
|
|
CRESY
1337
Cresud
CRESY
$752M
| $73K | ﹤0.01% |
5,802
+2,933
| +102% | +$32.4K |
|
1338
Invesco
IVZ
$14.3B
| $73K | ﹤0.01% |
2,774
-524
| -16% | -$12.8K |
|
1339
Kanzhun
BZ
$6.89B
| $71K | ﹤0.01% |
3,501
+328
| +10% | +$7.09K |
|
1340
Ouster
OUST
$3.25B
| $69K | ﹤0.01% |
3,195
-395
| -11% | -$10.4K |
|
1341
Twist Bioscience
TWST
$7.86B
| $66K | ﹤0.01% |
2,076
+1,034
| +99% | +$32.3K |
|
|
LKFT
1342
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
| $64K | ﹤0.01% |
1,968
+750
| +62% | +$24.2K |
|
1343
Seagate
STX
$209B
| $64K | ﹤0.01% |
233
+197
| +547% | +$51.1K |
|
1344
Teladoc Health
TDOC
$1.26B
| $64K | ﹤0.01% |
9,150
+4,607
| +101% | +$36.1K |
|
|
AXON
1345
Axon Enterprise
AXON
$50B
| $61K | ﹤0.01% |
108
+25
| +30% | +$15.5K |
|
1346
10x Genomics
TXG
$7.58B
| $60K | ﹤0.01% |
3,668
+1,695
| +86% | +$25.6K |
|
1347
GDS Holdings
GDS
$6.97B
| $59K | ﹤0.01% |
1,692
+1,202
| +245% | +$41.6K |
|
|
IRS
1348
IRSA Inversiones y Representaciones
IRS
$1.25B
| $58K | ﹤0.01% |
3,511
+1,415
| +68% | +$20.3K |
|
1349
NeoGenomics
NEO
$2.11B
| $58K | ﹤0.01% |
4,921
+2,619
| +114% | +$28.3K |
|
1350
Shinhan Financial Group
SHG
$35.1B
| $56K | ﹤0.01% |
+1,047
| New | +$55.2K |
|
Similar funds
VanEck Associates's Q4 2025 Portfolio in Review
As of Q4 2025, VanEck Associates held 1,514 positions worth $121B, up 12% from $108B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
VanEck Associates deployed $5.79B of net new capital in Q4 2025, opening 81 new positions and adding to 876 existing holdings. Its largest new stake was Standard Lithium: 15,539,435 shares worth $69.5M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 41% a quarter earlier, followed by Materials and Industrials.
On the sell side, the largest reduction was Applied Materials, an estimated $649M trimmed.
- VanEck Associates's largest Q4 2025 buy was Standard Lithium: 15,539,435 shares worth $69.5M.
- VanEck Associates added most to NVIDIA in Q4 2025, an estimated $1.9B increase.
- VanEck Associates's biggest Q4 2025 reduction was Applied Materials, cutting an estimated $649M.
- VanEck Associates fully exited Sandstorm Gold in Q4 2025, selling an estimated $298M.
- VanEck Associates's ten largest holdings make up 30% of its $121B portfolio in Q4 2025.
- VanEck Associates opened 81 new positions and closed 111 in Q4 2025.
- VanEck Associates's portfolio value rose 12% quarter-over-quarter to $121B.
Based on VanEck Associates's 13F filing for Q4 2025, filed 13 Feb 2026.